Qube Research & Technologies (QRT)
ASXC

Qube Research & Technologies (QRT)’s Asensus Surgical, Inc. ASXC Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio ASXC Stock Details ASXC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-129
Closed -$43 – 4341
2024
Q2 		$43 Hold
129
– – ﹤0.01% 3517
2024
Q1 		$30 Hold
129
– – ﹤0.01% 4245
2023
Q4 		$41 Hold
129
– – ﹤0.01% 4087
2023
Q3 		$35 Buy
+129
New +$47 ﹤0.01% 3843
2023
Q1 		– Sell
-18,778
Closed -$6.52K – 3136
2022
Q4 		$6.52K Sell
18,778
-169,405
-90% -$68.8K ﹤0.01% 2310
2022
Q3 		$84K Sell
188,183
-31,359
-14% -$16.4K ﹤0.01% 2024
2022
Q2 		$87K Buy
+219,542
New +$98K ﹤0.01% 1986
2021
Q2 		– Sell
-25,470
Closed -$83K – 2904
2021
Q1 		$83K Buy
25,470
+4,767
+23% +$17.3K ﹤0.01% 1754
2020
Q4 		$13K Buy
20,703
+2,187
+12% +$1K ﹤0.01% 1736
2020
Q3 		$6K Sell
18,516
-12,360
-40% -$4.79K ﹤0.01% 1597
2020
Q2 		$17K Buy
+30,876
New +$14.9K ﹤0.01% 1657

Other funds holding ASXC

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Qube Research & Technologies (QRT)'s ASXC Position: Q3 2024 in Review

Qube Research & Technologies (QRT) sold out of Asensus Surgical, Inc. (ASXC) in Q3 2024, closing a stake of 129 shares — an estimated $43 sold.

Qube Research & Technologies (QRT) first reported a position in ASXC in Q2 2020 and held it in 11 quarters. The position peaked at $87K in Q2 2022. 1 fund tracked by Wall St. Rank holds ASXC as of Q3 2024.

  • Qube Research & Technologies (QRT) reported no remaining Asensus Surgical, Inc. position as of Q3 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 129 Asensus Surgical, Inc. shares in Q3 2024, an estimated $43.
  • Qube Research & Technologies (QRT) first reported a position in Asensus Surgical, Inc. in Q2 2020 and held it in 11 quarters.
  • Qube Research & Technologies (QRT)'s Asensus Surgical, Inc. position peaked at $87K in Q2 2022.
  • 1 fund tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q3 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2024, filed 14 Nov 2024.